Dihexa (developmental code PNB-0408; also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is an oligopeptide drug derived from angiotensin IV that...
7 KB (492 words) - 08:38, 3 October 2024
and Parkinson's disease. It is a pro-drug of the active metabolite dihexa. Dihexa in turn binds to the hepatocyte growth factor (HGF) and potentiates...
3 KB (102 words) - 12:44, 8 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
121 KB (13,799 words) - 18:53, 22 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
68 KB (5,999 words) - 00:04, 25 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
92 KB (8,729 words) - 03:44, 26 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
149 KB (15,703 words) - 20:22, 18 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
42 KB (3,935 words) - 20:28, 27 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
12 KB (966 words) - 04:46, 15 July 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
13 KB (1,177 words) - 01:44, 4 November 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
18 KB (1,573 words) - 05:19, 15 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
14 KB (1,693 words) - 18:18, 18 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
34 KB (3,021 words) - 12:39, 5 August 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
12 KB (940 words) - 13:15, 23 October 2024
circulation by the liver, with a half-life of approximately 4 minutes. Dihexa is an orally active, centrally penetrant small-molecule compound that directly...
23 KB (2,635 words) - 06:03, 24 August 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
73 KB (6,455 words) - 04:22, 2 November 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
10 KB (600 words) - 04:23, 25 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
5 KB (412 words) - 23:17, 19 June 2023
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
35 KB (4,575 words) - 09:00, 2 November 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
25 KB (2,086 words) - 02:24, 16 July 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
21 KB (2,162 words) - 15:09, 19 August 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
17 KB (1,708 words) - 22:30, 15 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
20 KB (1,566 words) - 08:58, 12 August 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
43 KB (4,651 words) - 13:41, 27 July 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
23 KB (1,837 words) - 06:13, 31 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
110 KB (10,692 words) - 03:53, 30 September 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
10 KB (1,179 words) - 18:31, 8 August 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
24 KB (2,872 words) - 06:27, 22 July 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
71 KB (6,702 words) - 05:32, 9 August 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
64 KB (7,432 words) - 08:21, 28 October 2024
HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators: Dihexa (PNB-0408) Kinase inhibitors: Altiratinib AM7 AMG-458 Amuvatinib BMS-777607...
24 KB (2,882 words) - 16:31, 25 October 2024